Practice and prospect of treating aplastic anemia with integration of traditional Chinese and western medicine mainly with Chinese herbal medicines for tonifying kidney

WANG Wenru; DING Xiaoqing; TANG Xudong

doi:10.16025/j.1674-1307.2024.04.025

您当前的位置：

首页 >

文章列表页 >

Practice and prospect of treating aplastic anemia with integration of traditional Chinese and western medicine mainly with Chinese herbal medicines for tonifying kidney

更新时间：2024-06-03

- Practice and prospect of treating aplastic anemia with integration of traditional Chinese and western medicine mainly with Chinese herbal medicines for tonifying kidney
- Beijing Journal of Traditional Chinese Medicine Vol. 43, Issue 4, Pages: 438-442(2024)
- 作者机构：
  
  1.北京中医药大学东方医院血液科，北京 100078
  2.中国中医科学院西苑医院血液科，北京 100091
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2024.04.025
  CLC：
- Published：25 April 2024，
  
  Received：14 September 2023，
扫描看全文
王文儒，丁晓庆，唐旭东.补肾中药为主的中西医结合方法治疗再生障碍性贫血的实践与展望［J］.北京中医药，2024，43（4）：438-442.

WANG Wenru,DING Xiaoqing,TANG Xudong.Practice and prospect of treating aplastic anemia with integration of traditional Chinese and western medicine mainly with Chinese herbal medicines for tonifying kidney[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(04):438-442.
王文儒，丁晓庆，唐旭东.补肾中药为主的中西医结合方法治疗再生障碍性贫血的实践与展望［J］.北京中医药，2024，43（4）：438-442. DOI： 10.16025/j.1674-1307.2024.04.025.

WANG Wenru,DING Xiaoqing,TANG Xudong.Practice and prospect of treating aplastic anemia with integration of traditional Chinese and western medicine mainly with Chinese herbal medicines for tonifying kidney[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(04):438-442. DOI： 10.16025/j.1674-1307.2024.04.025.

摘要

再生障碍性贫血（aplastic anemia，AA）是一组以造血干细胞损伤、骨髓脂肪化、外周血全血细胞减少为特征的骨髓造血功能衰竭性疾病。中国中医科学院西苑医院血液科一直致力于AA的临床和基础研究，提出AA的病程大致可分为以异常免疫为主和以骨髓衰竭为主两个阶段，发现非重型再生障碍性贫血（non-severe aplastic anemia，NSAA）患者主要以肾阳虚型为主，重型AA（SAA）患者以肾阴虚型为主，血小板和网织红细胞能反映AA患者的临床疗效和累积生存率；临床采用以补肾中药为主的中西医结合方法治疗AA疗效显著，能有效改善患者免疫系统紊乱状态，为AA的中西医治疗推广提供依据。

Abstract

Aplastic anemia （AA） is a group of bone marrow hematopoietic failure characterized by hematopoietic stem cell injury， bone marrow adipose disease and peripheral blood pancytopenia disease. The Hematology Department of Xiyuan Hospital， China Academy of Chinese Medical Sciences has been devoted to the clinical and basic research of AA and first proposed that the occurrence and development of AA can be roughly divided into two stages， that is abnormal immunity and bone marrow failure. At the same time， it was found that the patients with kidney Yang deficiency type were mainly seen in NSAA patients， and kidney Yin deficiency type were mainly found in SAA patients.Platelets and reticulocytes can reflect the clinical efficacy and cumulative survival rate of AA patients；the clinical application of integrated traditional Chinese and western medicine based on Chinese herbal medicines for tonifying kidney has significant curative effect， which can effectively improve the immune system disorder of AA patients.On the basis of previous studies， we participated in the compilation of TCM clinical practice guidelines for AA， providing a basis for the promotion of integrative TCM and western medicine treatment for AA.

关键词

再生障碍性贫血中西医结合补肾中药

Keywords

Aplastic anemiaintegrated traditional Chinese and western medicineChinese herbal medicines for tonifying kidney

references

LI HC,ZHOU CJ,SHEN YY, et al. Research progress on the hematopoietic microenvironment in aplastic anemia[J]. Eur J Haematol, 2023,111(2):172-180.

中华医学血液学分会红细胞疾病学组.再生障碍性贫血诊断治疗专家共识[J].中华血液血杂志,2017,38(1):1-5.

DING SX,FU R. New trends in nontransplant therapy for acquired aplastic anemia[J]. Curr Pharm Des, 2022,28(21):1730-1737.

唐旭东,丁宇斌,麻柔.中西医结合治疗成人重型和输血依赖性非重型再生障碍性贫血体会[J].北京中医药,2020,39(2):160-163.

GIUDICE V,SELLERI C.Aplastic anemia:Pathophysiology[J]. Semin Hematol, 2022,59(1):13-20.

DURRANI J,GROARKE EM. Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation[J]. Semin Hematol, 2022,59(3):137-142.

唐旭东,麻柔,刘锋,等.再生障碍性贫血CD4+/CD8+T亚群的CD45RA+/RO+表达与中医辨证分型的相关性研究[J].四川中医,2006，24(1):14-16.

唐旭东,麻柔,刘锋,等.再生障碍性贫血患者T细胞CD45RA/RO表达与中医辨证分型的相关性[J].中医杂志,2006，47(3):212-214.

唐旭东,麻柔,刘锋,等.再生障碍性贫血γδT细胞亚群的表达与中医辨证分型的相关性研究[J].中华中医药杂志,2005，20(10):598-601.

JAVAN MR,SAKI NN,MOGHIMIAN-BOROUJENI B. Aplastic anemia, cellular and molecular aspects[J]. Cell Biol Int, 2021,45(12):2395-2402.

卢学春,杨波,迟小华,等.再生障碍性贫血病因学的新探索:异常免疫诱导骨髓间充质干细胞的过度脂肪化(英文)[J].解放军医学杂志,2014,39(3):173-179.

唐旭东,张姗姗,许勇钢,等.T胞亚群在重型再生障碍性贫血治疗中的疗效预测价值[J].中医杂志,2013,54(20):1755-1758.

唐旭东,张姗姗,麻柔,等.补肾中药为主的中西医结合治疗再生障碍性贫血的免疫学机制及疗效预测指标探讨[J].中华中医药杂志,2012,27(4):1101-1105.

唐旭东, 麻柔, 刘锋,等. 再生障碍性贫血中医辨证分型的客观量化与临床意义[J]. 中华中医药杂志,2008,23(9):780-783.

徐述,刘锋,麻柔.第八届全国中西医结合血液学学术会议纪要[J].中国中西医结合杂志,2008,28(2):187-188.

唐旭东,麻柔,刘锋等.补肾中药治疗再生障碍性贫血的系统评价[C].中国中西医结合学会血液学专业委员会.第八届全国中西医结合血液病学术会议论文集.[出版者不详],2007:1.

唐旭东,许勇钢,李柳,等.慢性再生障碍性贫血患者免疫球蛋白和补体水平与中医证型的相关性研究[J].国医论坛,2014,29(3):17-19.

NIEDERLOVA V,TSYKLAURI O,KOVAR M, et al. IL-2-driven CD8 T cell phenotypes: implications for immunotherapy[J]. Trends Immunol, 2023,44(11):890-901.

唐旭东,许勇钢,李柳,等.慢性再生障碍性贫血患者的细胞因子水平与中医证型的相关性研究[J].世界中西医结合杂志,2014,9(6):648-650.

李芮,丁宇斌,王文儒,等.补肾生血方治疗慢性再生障碍性贫血的临床疗效及对T细胞亚群、T-bet与GATA3表达的影响[J].中国实验方剂学杂志,2022,28(1 5):94-101.

杨晓红, 唐旭东, 许勇钢,等. 转录因子T-bet和GATA-3对再生障碍性贫血免疫失衡的作用[J]. 广东医学,2010,31(3):290-292.

唐旭东,麻柔,刘锋,等.再生障碍性贫血CD3+CD25+和CD3+HLA-DR+T细胞亚群的表达与中医辨证分型的相关性研究[J].中国中医基础医学杂志,2006，12(11):850-852.

李芮,唐旭东.基于“补肾健脾、益气补血”思路辨治慢性再生障碍性贫血[J].北京中医药,2021,40(7):730-731.

毛悦, 靳楠, 王文儒,等. 麻柔运用顾护脾胃冲和之气法治疗再生障碍性贫血经验[J]. 中国中医基础医学杂志,2023,29(10):1745-1748.

唐旭东,张姗姗,麻柔,等.再生障碍性贫血选用免疫抑制剂或雄激素治疗预测指标的初步研究[J].中国中西医结合杂志,2009,29(2):106-110.

唐旭东, 刘锋, 李柳,等. 以补肾中药为主联合抗淋巴细胞球蛋白/抗胸腺细胞球蛋白治疗重型再生障碍性贫血的预测因素[J]. 世界中医药,2018,13(4):813-817,821.

刘健, 李芮, 毛悦,等. 血肉有情之品治疗难治性再生障碍性贫血理论探析[J]. 浙江中医药大学学报,2022,46(2):161-165.

蒋佩珍, 丁宇斌, 王文儒,等. 补肾生血法与益气养血法联合西药治疗再生障碍性贫血的前瞻性随机双盲安慰剂对照的多中心临床研究[J]. 中医杂志,2022,63(11):1043-1050.

刘健,张朝畅,张盛琪,等.补肾填精方联合西药治疗再生障碍性贫血血小板影响因素的预测研究[J].世界中医药,2023,18(12):1708-1714.

吕妍, 李芮, 唐旭东. 补肾生血法和益气养血法治疗再生障碍性贫血的血常规变化规律比较及分阶段治疗模式[J]. 中国实验方剂学杂志,2023,29(14):73-79.

吴杰,潘琳莉,王静,等.补肾生血中药治疗慢性再生障碍性贫血疗效及对碱性成纤维细胞生长因子、Rho家族成员A蛋白水平的影响[J].现代中西医结合杂志,2017,26(24):2649-2651，2697.

唐旭东, 刘锋, 李柳,等. 补肾中药联合ATG或ALG治疗重型再生障碍性贫血预后因素分析[J]. 中国实验方剂学杂志,2011,17(8):250-254.

刘健,王文儒,丁宇斌,等.补肾填精方联合西药治疗再生障碍性贫血有效患者临床因素分析[J].中国中医药信息杂志,2022,29(7):127-133.

唐旭东, 刘锋, 李柳,等. 血小板计数在以补肾中药为主联合ATG/ALG治疗重型再障的预测作用[J]. 时珍国医国药,2018,29(5):1266-1270.

丁宇斌, 唐旭东. 肾阳虚型慢性再障患者CD3+CD19-和CD3+CD25+T细胞与血小板的多重线性回归分析[J]. 世界科学技术-中医药现代化,2020,22(11):3882-3886.

唐旭东,刘锋,李柳,等.网织红细胞计数在以补肾中药为主联合ATG/ALG治疗重型再生障碍性贫血中的预测作用[J].河南中医,2018,38(10):1546-1551.

王文儒,丁晓庆,杨秀鹏,等.补肾健脾方对再生障碍性贫血患者细胞自噬的影响[J].中国实验方剂学杂志,2023,29(14):80-87.

中国中医科学院. 中医循证临床实践指南［M］.北京:中国中医药出版社，2011:72-94．

中国中医科学院.中医循证临床实践指南［M］.2版.北京:中国中医药出版社，2020:79-86．

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

The multidisciplinary cooperation model of traditional Chinese and western medicine in the diagnosis and treatment of pediatric pulmonary allergic diseases

Related Author

HAO Jing

XIANG Li

JIANG Nan-nan

WANG Peng-peng

CHEN Li

Related Institution

Department of Traditional Chinese Medicine， Beijing Children's Hospital， Capital Medical University， National Center for Children's Health

Department of Allergy，Beijing Children's Hospital， Capital Medical University， National Center for Children's Health

Department of Otolaryngology Head and Neck Surgery， Beijing Children's Hospital， Capital Medical University， National Center for Children's Health

⁰